Related Experiment Video
Updated: Jul 16, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Sensory neuron BRAF mediates opioid-induced hyperalgesia and tolerance via presynaptic NMDA receptor hyperactivity
Abstract:
Opioids are essential analgesics for managing severe pain but can paradoxically increase pain sensitivity (hyperalgesia) and diminish analgesic efficacy (tolerance). Hyperactivity of NMDA-type glutamate receptors (NMDARs) at primary afferent terminals in the spinal cord contributes to both phenomena; however, the underlying signaling mechanisms remain unclear. Here, we report that morphine administration in rats promoted the translocation of monomeric BRAF, an oncogenic kinase, from the dorsal root ganglion (DRG) to spinal cord synaptosomes, leading to increased MEK-ERK phosphorylation at nociceptor central terminals. BRAF physically interacted with NMDARs in both rat and human spinal cords. Inhibition of BRAF activity with vemurafenib reversed morphine-induced NMDAR phosphorylation and synaptic localization of α2δ-1-bound NMDARs. Vemurafenib also abolished morphine-induced presynaptic NMDAR hyperactivity in spinal dorsal horn neurons. Correspondingly, conditional Braf knockout in DRG neurons normalized morphine-enhanced NMDAR phosphorylation, synaptic trafficking of α2δ-1-bound NMDARs, and NMDAR hyperactivity in the spinal cord. Furthermore, pharmacological inhibition of BRAF or MEK, or Braf deletion in DRG neurons, enhanced morphine analgesia while mitigating morphine-induced hyperalgesia and tolerance. These findings identify BRAF overactivity at nociceptor central terminals as a key mediator of opioid-induced NMDAR hyperactivity. Clinically approved BRAF inhibitors could be repurposed to enhance opioid analgesia while minimizing adverse effects.
Insights
Opioid-induced pain hypersensitivity and tolerance involve NMDA receptor (NMDAR) hyperactivity. BRAF kinase translocation to spinal cord synaptosomes drives this NMDAR overactivity, impacting pain management.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Opioids are vital for severe pain but cause hyperalgesia and tolerance.
- NMDA receptor (NMDAR) hyperactivity in the spinal cord contributes to these opioid-induced effects.
- The precise signaling pathways driving NMDAR hyperactivity remain poorly understood.
Purpose of the Study:
- To elucidate the molecular mechanisms linking opioid administration to NMDAR hyperactivity.
- To investigate the role of BRAF kinase in mediating opioid-induced hyperalgesia and tolerance.
- To explore the therapeutic potential of targeting BRAF for improved opioid analgesia.
Main Methods:
- Morphine administration in rats to induce hyperalgesia and tolerance.
- Assessment of BRAF translocation, MEK-ERK phosphorylation, and NMDAR activity in spinal cord synaptosomes.
- Pharmacological inhibition of BRAF (vemurafenib) and MEK.
- Conditional knockout of Braf in dorsal root ganglion (DRG) neurons.
- Electrophysiological recordings of NMDAR hyperactivity in spinal dorsal horn neurons.
- Evaluation of analgesic effects, hyperalgesia, and tolerance in response to BRAF inhibition or Braf deletion.
Main Results:
- Morphine promoted BRAF translocation to spinal cord synaptosomes, increasing MEK-ERK phosphorylation.
- BRAF physically interacted with NMDARs in both rat and human spinal cords.
- BRAF inhibition (vemurafenib) or Braf deletion reversed morphine-induced NMDAR phosphorylation, trafficking, and hyperactivity.
- Targeting BRAF or MEK, or deleting Braf, enhanced morphine analgesia and reduced hyperalgesia and tolerance.
Conclusions:
- BRAF overactivity at nociceptor central terminals is a key mediator of opioid-induced NMDAR hyperactivity.
- BRAF kinase signaling is critical for the development of opioid-induced hyperalgesia and tolerance.
- Clinically approved BRAF inhibitors may offer a strategy to enhance opioid efficacy and mitigate adverse effects.
Related Concept Videos
Analgesia and Pain Management
Nociception
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Somatosensation
Pain

